AMY ZELLER: Open Payments
NPI 1326539859 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 75 payments from 16 companies in 2025. Trend: 2023 $1,898 · 2024 $1,369 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $439 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $149 |
| PFIZER INC. | 20 | $146 |
| Lilly USA, LLC | 5 | $105 |
| Novo Nordisk Inc | 4 | $77 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Amgen Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $35 |
Products named: AIRSUPRA, CAPLYTA, NURTEC ODT, BREZTRI, FARXIGA, MOUNJARO, GEMTESA, OTEZLA.
Industry payments across IL — which companies pay providers there.
